# A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People

> **NCT05580003** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 94 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-07817883
- **DRUG:** Placebo
- **DRUG:** Midazolam
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT05580003
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-17
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05580003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05580003, "A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05580003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*